Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DFNS vs MRNA✓SelectedUSD · MRNADFNS vs MRNA performance historyLatest closeAs of-11.11%11/16
Stock and ETF performance explorer

DFNS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-100.0%
MRNA return
-8.0%
Excess return
-92.0%
Maximum drawdown
-100.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-11.1%-3.6%-7.5%-11.2%
7D-13.8%-20.0%+6.1%-14.3%
30D-65.1%-1.3%-63.9%-65.1%
3M-95.0%+240.0%-335.0%-94.7%
6M-97.0%+339.0%-435.9%-96.7%
YTD-99.7%+630.0%-729.6%-99.6%
1Y-99.7%+769.1%-868.8%-99.6%
3Y-100.0%+181.2%-281.2%-100.0%
5Y-100.0%-8.1%-91.9%-100.0%
All-100.0%-8.0%-92.0%-100.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling